# Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity

> **NCT00277641** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 70 (estimated)

## Conditions studied

- Binge Eating Disorder
- Obesity

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00277641
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277641, "Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00277641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*